Wound Care Biologics Market
Wound Care Biologics Market Analysis, By Product (Biologic Skin Substitutes, Topical Agents), By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns), By End User (Hospitals, Ambulatory Surgical Centers, Burn Centers & Wound Clinics), & By Region - Global Market Insights 2022-2032
Analysis of Wound Care Biologics Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Wound Care Biologics Market Outlook (2022-2032)
The global wound care biologics market is currently valued at US$ 2.09 billion. Worldwide demand for wound care biologics is predicted to rise at a high-value CAGR of 11% and reach US$ 5.93 billion by the end of 2032.
Wound care biologics products are further classified into biological skin substitutes and topical agents. Sales of biological skin substitutes are expected to increase at a CAGR of 11.5% during the forecast period.
Biological skin substitutes are a diverse range of materials used for wound closure. Patients with severe burns are primarily treated using biological skin substitutes. The biological skin substitutes also enable the development of a more natural new dermis, ensuring that wounds heal quickly.
Sales of biologic skin substitutes are expected to be primarily driven by the increasing number of burn injuries and chronic wounds. Chronic wounds may further lead to severe infections, ulcers, and insufficient blood flow.
- According to a study titled "The Role of Advanced Biologics (Skin Substitutes) in Wound Healing" that was published in The Wound Docs in December 2021, inexpensive, easily accessible biological skin substitutes allow for considerable re-epithelialization. The most often utilised biological skin substitutes are cadaver allografts, amnion, and porcine skin xenografts.
For the treatment of chronic injuries, such as diabetic foot ulcers and venous ulcers, as well as burn injuries, and injuries sustained in auto accidents, biological skin substitutes are strongly advised.
New developments in skin tissue engineering such as the use of 3D printers have increased its acceptance among surgeons, driving up the demand for biological skin substitutes. One of the helpful instruments in reconstructive surgical procedures that are frequently utilised as an alternative to skin grafts is biological skin substitutes.
For breast reconstruction surgeries, an allogenic acellular dermal matrix is highly preferred. Furthermore, products made of an acellular dermal matrix are used to treat diabetic lower extremity ulcers. The sales growth would be driven by the high employment of such excellent biological skin substitutes in aesthetic operations during the forecast period.
- For instance, Integra LifeSciences introduced the Amnio Excel Plus Placental Allograft Membrane in February 2020. It helps soft tissue repair and is their latest solution in terms of biological wound healing treatment.
- A novel placental membrane-based product called Enverse, used for acute and chronic wounds, was also introduced in July 2022 by StimLabs, LLC, a pioneer in regenerative technologies and solutions that are redefining patient care via innovation and individualized solutions.
The use of cotton gins for wound management dates back to 1793, marking the beginning of the wound care biologics sector. The wound care biologics business has undergone tremendous change since then.
As antiseptic dressings offered quicker wound healing with minimal microbial activity, they eventually supplanted the standard bandages that were previously available. Currently, due to advancements in research and studies, topical agents and biotechnologically created skin have revolutionized the wound healing process, making it more convenient and simple.
Hemostasis, inflammation, proliferation, and remodelling are all important biological processes that take place during wound healing. Several different cell types, such as neutrophils, lymphocytes, macrophages, fibroblasts, keratinocytes, and endothelial cells, are heavily involved in this process.
Technological advancements, rising cases of chronic illness, an increase in accidents and trauma, and a rise in the number of elderly people with chronic wound diseases such as diabetes are all contributing to the rising demand for wound biologics.
Report Attributes |
Details |
|---|---|
|
Wound Care Biologics Market Size (2022E) |
US$ 2.09 Billion |
|
Forecasted Market Value (2032F) |
US$ 5.93 Billion |
|
Global Market Growth Rate (2022-2032) |
11% CAGR |
|
China Market Growth Rate (2022-2032) |
16% CAGR |
|
Key Companies Profiled |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
What are the Demand Growth Drivers for Wound Care Biologics Products?
“Growing Cases of Burn Injuries Worldwide”
The growth of the wound care biologics market will be positively impacted by the rising number of burn injuries, particularly in developing and underdeveloped nations. There are many cases of burns in nations such as Brazil and Africa.
- For instance, the WHO estimates that each year in low- and middle-income countries, burns account for over 180,000 fatalities.
Burns have terrible consequences on the victim's skin in addition to significant financial consequences. Also, there are various treatment methods for burns, which are categorised based on the severity of the injury.
One of the most popular treatments for burns is wound care biologics since it promotes a quick recovery with few to no complications. Therefore, the availability of high-quality synthetic replacements and the rising demand for them in the treatment of burns have been advantageous for the industry's development.
“Rising Prevalence of Diabetic Foot Ulcers”
Since diabetic individuals are more likely to develop diabetic ulcers, the demand for wound care biologics is expected to increase significantly as diabetes incidence increases globally.
- For instance, the prevalence of diabetes is rising across the globe, primarily as a result of obesity, a poor diet, and a lack of exercise.
- A study titled "Diabetic Foot Ulcer" which was published in the National Library of Medicine in May 2022 estimates that there are between 9.1 and 26.1 million diabetic foot ulcers each year throughout the world.
A diabetic foot ulcer has been experienced by 15% to 25% of patients with diabetes mellitus at some time in their lives. The prevalence of diabetic foot ulcers will inevitably increase as more people are diagnosed with the disease each year worldwide. Therefore, demand for wound care biologics is anticipated to rise during the forecast period.
What Could Possibly Stunt Demand for Wound Care Biologics Treatment?
“High Cost of Treatment & Risk of Treatment Failure”
It is anticipated that the high cost of wound care biologics and wound treatment will impede sales growth. The risk of skin substitute failure is anticipated to pose an obstacle to wound care biologics manufacturers throughout the forecast period.
Which Regional Market is Considered Lucrative for Wound Care Biologics Treatment Providers?
“Rise in Traffic Accidents & Presence of Advanced Healthcare Infrastructure in North America”
The market in North America is predicted to be driven by an increase in traffic accidents, a rise in the cases of chronic diseases, and the existence of numerous major competitors in the region.
During the projected period, this demand is also expected to be influenced by advancements in healthcare infrastructure and the presence of skilled medical experts.
Over the forecast period, the Asia Pacific market is anticipated to experience the quickest development. It is projected that the prominence of the major marketplace such as China, India, South Korea, and Japan will accelerate sales growth in the Asia Pacific region. Furthermore, the prevalence of chronic diseases, particularly diabetes, is predicted to boost sales of wound care biologics.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Analysis
How is Demand for Wound Care Biologics Treatment Expected to Shape Up in the U.S.?
“Aesthetic Operations Highly Popular in Nation”
Increasing prevalence of diabetic foot ulcers can be ascribed to the high sales growth of wound care biologics.
- About 10% of diabetic patients experience chronic foot ulcers, according to Azura Vascular Care.
Diabetes patients' bodies don't get enough oxygen, which slows down wound healing and makes them more vulnerable to bacterial and fungal skin conditions.
Moreover, during the anticipated period, the demand for biological skin substitutes in aesthetic operations would boost the growth of the U.S. wound care biologics market.
What is Supporting Sales of Wound Care Biologics in European Countries?
“Growing Awareness of Advanced Wound Care Treatment & High Prevalence of Gestational Diabetes”
In European nations such as the U.K., Spain, France, and Germany, growing awareness of advanced wound care treatment products is anticipated to generate lucrative growth prospects.
There is a belief that factors such as rising obesity and lack of exercise are contributing to the prevalence of diabetes.
In addition to diabetes, breast cancer is becoming more common in the UK. There is a significant demand for advanced wound care treatment in the nation due to the increase in frequency and complexity of breast surgical operations.
In Germany, there is a high prevalence of gestational diabetes in women. Thus, it is anticipated that the aforementioned factors will increase the sales of biologics for wound care in European nations.
Category-wise Analysis
Which Wound Type Accounts for High Demand for Wound Care Biologics?
“Burns & Other Acute Wounds Most Common Across Globe”
Wound care biologics are typically used to treat wounds such as ulcers, surgical & traumatic wounds, and burns.
Burns and other acute wounds, such as surgical and traumatic wounds, are quite common around the world. There is high demand for wound care biologics due to rising cases of diabetes wounds, across the globe.
Diabetes wounds are caused due to excessive blood sugar levels, which frequently result in hormonal imbalance and diseases such as chronic foot ulcers.
- According to OxyGeneration, at least 15% to 20% of patients with diabetes will develop foot ulcers.
Clinical professionals typically favour biologics for wound treatment that promote a suitable environment for healing.
Demand for wound care biologics will increase as pressure ulcer wounds such as bed sores become more common. Additionally, the presence of significant side effects such as cellulites, bacteremia, sepsis, and septic arthritis in patients with pressure ulcers increases the sales of wound care biologics.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Competitive Landscape
Key players in the wound care biologics market are Acell, Anika Therapeutics, Integra Lifesciences, Kerecis, Marine Polymer Technologies, Mimedx Group, Mölnlycke Health Care AB (Investor AB), Organogenesis, Osiris Therapeutics, and Smith & Nephew.
Sales will rise over the coming years as a result of advancements in biologic wound healing treatment. To create high-quality wound care biologic solutions, major companies in the wound care biologics business spend a lot of money on research and development.
- The tri-layer skin graft Artacent AC, manufactured by the biologics business Tides Medical, was introduced in July 2022 to treat complicated or challenging-to-treat wounds.
- The department of U.S. defence awarded MIMEDX USD 4.6 million in May 2022 to investigate PURION-processed Dehydrated Human Amnion Chorion Membrane (DHACM) to advance the treatment of burns and wounds sustained during warfare.
Key Segments of Wound Care Biologics Industry Research
-
By Product:
- Biologic Skin Substitutes
- Topical Agents
-
By Wound Type:
- Ulcers
- Surgical & Traumatic Wounds
- Burns
-
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Burn Centers & Wound Clinics
-
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
1. Global Wound Care Biologics Market - Executive Summary 1.1. Global Market Overview 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Fact.MR Analysis and Recommendations 2. Global Wound Care Biologics Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Introduction and Definition 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Wound Care Biologics 3.1.2. COVID-19 Crisis and Impact on Aprotic Solvent Prices 3.1.3. COVID-19 Impact Benchmark with Previous Crisis 3.1.3.1. Change in Wound Care Biologics Demand 3.1.3.2. Before and After COVID-19 Crisis (Projected) 3.1.3.3. Before and After Sub-prime Crisis – 2008 (Actual) 3.1.3.4. Change in Demand post Recovery Period (After Each Crisis) 3.1.4. Impact on Market and Value (US$ Mn) 3.1.4.1. Likely Loss of Value in 2020 3.1.4.2. Mid-term and Long Term Forecast 3.1.4.3. Quarter by Quarter Demand and Recovery Assessment 3.1.5. Anticipated Demand and Value Recovery Curve 3.1.5.1. Likelihood of U-Shape Recovery 3.1.5.2. Likelihood of L-Shape Recovery 3.1.6. Recovery Period Assessment by Key Countries 3.1.7. Recovery Assessment by Key Market Segments 3.1.8. Action Points and Recommendations for Suppliers 3.1.9. Impact on Trade Balance 3.2. Key Trends Impacting the Market 3.3. Formulation and Wound Type Development Trends 4. Market Background and foundation Data Points 4.1. Need of the Hour for Industries 4.2. Industry Wise Industry 4.0 4.3. Wound Care Biologics – Strategic Priorities 4.4. Life Cycle Stage 4.5. Importance of Technology 4.6. Use Cases of Wound Care Biologics 4.7. Forecast Factors: Relevance and Impact 4.8. Investment Feasibility Matrix 4.9. PESTLE Analysis 4.10. Porter’s Five Forces Analysis 4.11. Market Dynamics 4.11.1. Drivers 4.11.2. Restraints 4.11.3. Opportunity Analysis 4.11.4. Trend 5. Global Wound Care Biologics Market Demand (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032 5.1. Historical Market Value (US$ Mn) Analysis, 2017-2021 5.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032 5.2.1. Y-o-Y Growth Trend Analysis 5.2.2. Absolute $ Opportunity Analysis 6. Global Wound Care Biologics Market Analysis 2017-2021 and Forecast 2022-2032, By Wound Type 6.1. Introduction / Key Findings 6.2. Historical Market Value (US$ Mn) Analysis By Wound Type, 2017-2021 6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Wound Type, 2022-2032 6.3.1. Ulcers 6.3.2. Surgical & Traumatic Wounds 6.3.3. Burns 6.4. Market Attractiveness Analysis By Wound Type 7. Global Wound Care Biologics Market Analysis 2017-2021 and Forecast 2022-2032, by Product 7.1. Introduction / Key Findings 7.2. Historical Market Value (US$ Mn) Analysis By Product , 2017-2021 7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Product, 2022-2032 7.3.1. Biologic Skin Substitutes 7.3.2. Topical Agents 7.4. Market Attractiveness Analysis By Product 8. Global Wound Care Biologics Market Analysis 2017-2021 and Forecast 2022-2032, by End User 8.1. Introduction / Key Findings 8.2. Historical Market Value (US$ Mn) Analysis By End User, 2017-2021 8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By End User, 2022-2032 8.3.1. Hospitals 8.3.2. Ambulatory Surgical Centers 8.3.3. Burn Centers & Wound Clinics 8.4. Market Attractiveness Analysis By End User 9. Global Wound Care Biologics Market Analysis 2017-2021 and Forecast 2022-2032, by Region 9.1. Introduction / Key Findings 9.2. Historical Market Value (US$ Mn) Analysis By Region, 2017-2021 9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. East Asia 9.3.5. South Asia & Oceania 9.3.6. Middle East and Africa (MEA) 9.4. Market Attractiveness Analysis By Region 10. North America Wound Care Biologics Market Analysis 2017-2021 and Forecast 2022-2032 10.1. Introduction / Key Findings 10.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.3.1. By Country 10.3.1.1. U.S. 10.3.1.2. Canada 10.3.2. By Wound Type 10.3.3. By Product 10.4. Market Attractiveness Analysis 10.4.1. By Country 10.4.2. By Wound Type 10.4.3. By Product 11. Latin America Wound Care Biologics Market Analysis 2017-2021 and Forecast 2022-2032 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 11.3.1. By Country 11.3.1.1. Brazil 11.3.1.2. Mexico 11.3.1.3. Rest of Latin America 11.3.2. By Wound Type 11.3.3. By Product 11.3.4. By End User 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Wound Type 11.4.3. By Product 11.4.4. By End User 12. Europe Wound Care Biologics Market Analysis 2017-2021 and Forecast 2022-2032 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 12.3.1. By Country 12.3.1.1. Germany 12.3.1.2. France 12.3.1.3. Italy 12.3.1.4. Spain 12.3.1.5. UK 12.3.1.6. BENELUX 12.3.1.7. Russia 12.3.1.8. Rest of Europe 12.3.2. By Wound Type 12.3.3. By Product 12.3.4. By End User 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Wound Type 12.4.3. By Product 12.4.4. By End User 13. East Asia Wound Care Biologics Market Analysis 2017-2021 and Forecast 2022-2032 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 13.3.1. By Country 13.3.1.1. China 13.3.1.2. Japan 13.3.1.3. South Korea 13.3.2. By Wound Type 13.3.3. By Product 13.3.4. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Wound Type 13.4.3. By Product 13.4.4. By End User 14. South Asia & Oceania Wound Care Biologics Market Analysis 2017-2021 and Forecast 2022-2032 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Thailand 14.3.1.3. Malaysia 14.3.1.4. Singapore 14.3.1.5. Vietnam 14.3.1.6. ANZ 14.3.1.7. Rest of South Asia & Oceania 14.3.2. By Wound Type 14.3.3. By Product 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Wound Type 14.4.3. By Product 14.4.4. By End User 15. Middle East and Africa Wound Care Biologics Market Analysis 2017-2021 and Forecast 2022-2032 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 15.3.1. By Country 15.3.1.1. GCC Countries 15.3.1.2. South Africa 15.3.1.3. Israel 15.3.1.4. Rest of Middle East and Africa (MEA) 15.3.2. By Wound Type 15.3.3. By Product 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Wound Type 15.4.3. By Product 15.4.4. By End User 16. Market Structure Analysis 16.1. Market Analysis by Tier of Companies 16.2. Market Concentration 16.3. Market Share Analysis of Top Players 16.4. Market Presence Analysis 17. Competition Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Competition Deep Dive 17.3.1. Acell 17.3.1.1. Company Overview 17.3.1.2. Wound Type overview 17.3.1.3. SWOT Analysis 17.3.1.4. Key Developments 17.3.2. Anika Therapeutics 17.3.2.1. Company Overview 17.3.2.2. Wound Type overview 17.3.2.3. SWOT Analysis 17.3.2.4. Key Developments 17.3.3. Integra Lifesciences 17.3.3.1. Company Overview 17.3.3.2. Wound Type overview 17.3.3.3. SWOT Analysis 17.3.3.4. Key Developments 17.3.4. Kerecis 17.3.4.1. Company Overview 17.3.4.2. Wound Type overview 17.3.4.3. SWOT Analysis 17.3.4.4. Key Developments 17.3.5. Marine Polymer Technologies 17.3.5.1. Company Overview 17.3.5.2. Wound Type overview 17.3.5.3. SWOT Analysis 17.3.5.4. Key Developments 17.3.6. Mimedx Group 17.3.6.1. Company Overview 17.3.6.2. Wound Type overview 17.3.6.3. SWOT Analysis 17.3.6.4. Key Developments 17.3.7. Mölnlycke Health Care AB (Investor AB) 17.3.7.1. Company Overview 17.3.7.2. Wound Type overview 17.3.7.3. SWOT Analysis 17.3.7.4. Key Developments 17.3.8. Organogenesis 17.3.8.1. Company Overview 17.3.8.2. Wound Type overview 17.3.8.3. SWOT Analysis 17.3.8.4. Key Developments 17.3.9. Osiris Therapeutics 17.3.9.1. Company Overview 17.3.9.2. Wound Type overview 17.3.9.3. SWOT Analysis 17.3.9.4. Key Developments 17.3.10. Smith & Nephew 17.3.10.1. Company Overview 17.3.10.2. Wound Type overview 17.3.10.3. SWOT Analysis 17.3.10.4. Key Developments 18. Assumptions And Acronyms Used 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Wound Care Biologics Market Value (US$ Mn) Analysis, by Wound Type, 2017-2021
Table 02: Global Wound Care Biologics Market Value (US$ Mn) Analysis, by Wound Type, 2022-2032
Table 03: Global Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by Wound Type, 2022-2032
Table 04: Global Wound Care Biologics Market Value (US$ Mn) Analysis, by Product, 2017-2021
Table 05: Global Wound Care Biologics Market Value (US$ Mn) Analysis, by Product, 2022-2032
Table 06: Global Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by Product, 2022-2032
Table 07: Global Wound Care Biologics Market Value (US$ Mn) Analysis, by End User, 2017-2021
Table 08: Global Wound Care Biologics Market Value (US$ Mn) Analysis, by End User, 2022-2032
Table 09: Global Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by End User, 2022-2032
Table 10: Global Wound Care Biologics Market Value (US$ Mn) Analysis, by Region, 2017-2021
Table 11: Global Wound Care Biologics Market Value (US$ Mn) Analysis, by Region, 2022-2032
Table 12: Global Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by Region, 2022-2032
Table 13: North America Wound Care Biologics Market Value (US$ Mn) Analysis, by Country, 2017-2021
Table 14: North America Wound Care Biologics Market Value (US$ Mn) Analysis, by Country, 2022-2032
Table 15: North America Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2032
Table 16: North America Wound Care Biologics Market Value (US$ Mn) Analysis, by Wound Type, 2017-2021
Table 17: North America Wound Care Biologics Market Value (US$ Mn) Analysis, by Wound Type, 2022-2032
Table 18: North America Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by Wound Type, 2022-2032
Table 19: North America Wound Care Biologics Market Value (US$ Mn) Analysis, by Product, 2017-2021
Table 20: North America Wound Care Biologics Market Value (US$ Mn) Analysis, by Product, 2022-2032
Table 21: North America Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by Product, 2022-2032
Table 22: North America Wound Care Biologics Market Value (US$ Mn) Analysis, by End User, 2017-2021
Table 23: North America Wound Care Biologics Market Value (US$ Mn) Analysis, by End User, 2022-2032
Table 24: North America Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by End User, 2022-2032
Table 25: Latin America Wound Care Biologics Market Value (US$ Mn) Analysis, by Country, 2017-2021
Table 26: Latin America Wound Care Biologics Market Value (US$ Mn) Analysis, by Country, 2022-2032
Table 27: Latin America Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2032
Table 28: Latin America Wound Care Biologics Market Value (US$ Mn) Analysis, by Wound Type, 2017-2021
Table 29: Latin America Wound Care Biologics Market Value (US$ Mn) Analysis, by Wound Type, 2022-2032
Table 30: Latin America Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by Wound Type, 2022-2032
Table 31: Latin America Wound Care Biologics Market Value (US$ Mn) Analysis, by Product, 2017-2021
Table 32: Latin America Wound Care Biologics Market Value (US$ Mn) Analysis, by Product, 2022-2032
Table 33: Latin America Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by Product, 2022-2032
Table 34: Latin America Wound Care Biologics Market Value (US$ Mn) Analysis, by End User, 2017-2021
Table 35: Latin America Wound Care Biologics Market Value (US$ Mn) Analysis, by End User, 2022-2032
Table 36: Latin America Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by End User, 2022-2032
Table 37: Europe Wound Care Biologics Market Value (US$ Mn) Analysis, by Country, 2017-2021
Table 38: Europe Wound Care Biologics Market Value (US$ Mn) Analysis, by Country, 2022-2032
Table 39: Europe Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2032
Table 40: Europe Wound Care Biologics Market Value (US$ Mn) Analysis, by Wound Type, 2017-2021
Table 41: Europe Wound Care Biologics Market Value (US$ Mn) Analysis, by Wound Type, 2022-2032
Table 42: Europe Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by Wound Type, 2022-2032
Table 43: Europe Wound Care Biologics Market Value (US$ Mn) Analysis, by Product, 2017-2021
Table 44: Europe Wound Care Biologics Market Value (US$ Mn) Analysis, by Product, 2022-2032
Table 45: Europe Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by Product, 2022-2032
Table 46: Europe Wound Care Biologics Market Value (US$ Mn) Analysis, by End User, 2017-2021
Table 47: Europe Wound Care Biologics Market Value (US$ Mn) Analysis, by End User, 2022-2032
Table 48: Europe Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by End User, 2022-2032
Table 49: East Asia Wound Care Biologics Market Value (US$ Mn) Analysis, by Country, 2017-2021
Table 50: East Asia Wound Care Biologics Market Value (US$ Mn) Analysis, by Country, 2022-2032
Table 51: East Asia Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2032
Table 52: East Asia Wound Care Biologics Market Value (US$ Mn) Analysis, by Wound Type, 2017-2021
Table 53: East Asia Wound Care Biologics Market Value (US$ Mn) Analysis, by Wound Type, 2022-2032
Table 54: East Asia Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by Wound Type, 2022-2032
Table 55: East Asia Wound Care Biologics Market Value (US$ Mn) Analysis, by Product, 2017-2021
Table 56: East Asia Wound Care Biologics Market Value (US$ Mn) Analysis, by Product, 2022-2032
Table 57: East Asia Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by Product, 2022-2032
Table 58: East Asia Wound Care Biologics Market Value (US$ Mn) Analysis, by End User, 2017-2021
Table 59: East Asia Wound Care Biologics Market Value (US$ Mn) Analysis, by End User, 2022-2032
Table 60: East Asia Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by End User, 2022-2032
Table 61: South Asia & Oceania Wound Care Biologics Market Value (US$ Mn) Analysis, by Country, 2017-2021
Table 62: South Asia & Oceania Wound Care Biologics Market Value (US$ Mn) Analysis, by Country, 2022-2032
Table 63: South Asia & Oceania Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2032
Table 64: South Asia & Oceania Wound Care Biologics Market Value (US$ Mn) Analysis, by Wound Type, 2017-2021
Table 65: South Asia & Oceania Wound Care Biologics Market Value (US$ Mn) Analysis, by Wound Type, 2022-2032
Table 66: South Asia & Oceania Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by Wound Type, 2022-2032
Table 67: South Asia & Oceania Wound Care Biologics Market Value (US$ Mn) Analysis, by Product, 2017-2021
Table 68: South Asia & Oceania Wound Care Biologics Market Value (US$ Mn) Analysis, by Product, 2022-2032
Table 69: South Asia & Oceania Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by Product, 2022-2032
Table 70: South Asia & Oceania Wound Care Biologics Market Value (US$ Mn) Analysis, by End User, 2017-2021
Table 71: South Asia & Oceania Wound Care Biologics Market Value (US$ Mn) Analysis, by End User, 2022-2032
Table 72: South Asia & Oceania Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by End User, 2022-2032
Table 73: MEA Wound Care Biologics Market Value (US$ Mn) Analysis, by Country, 2017-2021
Table 74: MEA Wound Care Biologics Market Value (US$ Mn) Analysis, by Country, 2022-2032
Table 75: MEA Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2032
Table 76: MEA Wound Care Biologics Market Value (US$ Mn) Analysis, by Wound Type, 2017-2021
Table 77: MEA Wound Care Biologics Market Value (US$ Mn) Analysis, by Wound Type, 2022-2032
Table 78: MEA Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by Wound Type, 2022-2032
Table 79: MEA Wound Care Biologics Market Value (US$ Mn) Analysis, by Product, 2017-2021
Table 80: MEA Wound Care Biologics Market Value (US$ Mn) Analysis, by Product, 2022-2032
Table 81: MEA Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by Product, 2022-2032
Table 82: MEA Wound Care Biologics Market Value (US$ Mn) Analysis, by End User, 2017-2021
Table 83: MEA Wound Care Biologics Market Value (US$ Mn) Analysis, by End User, 2022-2032
Table 84: MEA Wound Care Biologics Market Value (US$ Mn) Opportunity Analysis, by End User, 2022-2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Wound Care Biologics Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 02: Global Wound Care Biologics Market Value (US$ Mn) Forecast and Analysis, 2022-2032
Figure 03: Global Wound Care Biologics Market Value Y-o-Y Growth and Forecast, 2017-2032
Figure 04: Global Wound Care Biologics Market Incremental $ Opportunity, 2022-2032
Figure 05: Global Wound Care Biologics Market Share and BPS Analysis by Wound Type, 2022 & 2032
Figure 06: Global Wound Care Biologics Market Y-o-Y Growth Projections by Wound Type, 2022-2032
Figure 07: Global Wound Care Biologics Market Attractiveness Analysis by Wound Type, 2022-2032
Figure 08: Global Wound Care Biologics Market Share and BPS Analysis by Product, 2022 & 2032
Figure 09: Global Wound Care Biologics Market Y-o-Y Growth Projections by Product, 2022-2032
Figure 10: Global Wound Care Biologics Market Attractiveness Analysis by Product, 2022-2032
Figure 11: Global Wound Care Biologics Market Share and BPS Analysis by End User, 2022 & 2032
Figure 12: Global Wound Care Biologics Market Y-o-Y Growth Projections by End User, 2022-2032
Figure 13: Global Wound Care Biologics Market Attractiveness Analysis by End User, 2022-2032
Figure 14: Global Wound Care Biologics Market Share and BPS Analysis by Region, 2022 & 2032
Figure 15: Global Wound Care Biologics Market Y-o-Y Growth Projections by Region, 2022-2032
Figure 16: Global Wound Care Biologics Market Attractiveness Analysis by Region, 2022-2032
Figure 17: North America Wound Care Biologics Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 18: North America Wound Care Biologics Market Value (US$ Mn) Forecast and Analysis, 2022-2032
Figure 19: North America Wound Care Biologics Market Value Y-o-Y Growth and Forecast, 2032
Figure 20: North America Wound Care Biologics Market Incremental $ Opportunity, 2022-2032
Figure 21: North America Wound Care Biologics Market Share Analysis by Country, 2022 & 2032
Figure 22: North America Wound Care Biologics Market Y-o-Y Growth Projection by Country, 2022-2032
Figure 23: North America Wound Care Biologics Market Attractiveness Analysis by Country, 2022-2032
Figure 24: North America Wound Care Biologics Market Share and BPS Analysis by Wound Type, 2022 & 2032
Figure 25: North America Wound Care Biologics Market Y-o-Y Growth Projections by Wound Type, 2022-2032
Figure 26: North America Wound Care Biologics Market Attractiveness Analysis by Wound Type, 2022-2032
Figure 27: North America Wound Care Biologics Market Share and BPS Analysis by Product, 2022 & 2032
Figure 28: North America Wound Care Biologics Market Y-o-Y Growth Projections by Product, 2022-2032
Figure 29: North America Wound Care Biologics Market Attractiveness Analysis by Product, 2022-2032
Figure 30: North America Wound Care Biologics Market Share and BPS Analysis by End User, 2022 & 2032
Figure 31: North America Wound Care Biologics Market Y-o-Y Growth Projections by End User, 2022-2032
Figure 32: North America Wound Care Biologics Market Attractiveness Analysis by End User, 2022-2032
Figure 33: Latin America Wound Care Biologics Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 34: Latin America Wound Care Biologics Market Value (US$ Mn) Forecast and Analysis, 2022-2032
Figure 35: Latin America Wound Care Biologics Market Value Y-o-Y Growth and Forecast, 2017-2032
Figure 36: Latin America Wound Care Biologics Market Incremental $ Opportunity, 2022-2032
Figure 37: Latin America Wound Care Biologics Market Share Analysis by Country, 2022 & 2032
Figure 38: Latin America Wound Care Biologics Market Y-o-Y Growth Projection by Country, 2022-2032
Figure 39: Latin America Wound Care Biologics Market Attractiveness Analysis by Country, 2022-2032
Figure 40: Latin America Wound Care Biologics Market Share and BPS Analysis by Wound Type, 2022 & 2032
Figure 41: Latin America Wound Care Biologics Market Y-o-Y Growth Projections by Wound Type, 2022-2032
Figure 42: Latin America Wound Care Biologics Market Attractiveness Analysis by Wound Type, 2022-2032
Figure 43: Latin America Wound Care Biologics Market Share and BPS Analysis by Product, 2022 & 2032
Figure 44: Latin America Wound Care Biologics Market Y-o-Y Growth Projections by Product, 2022-2032
Figure 45: Latin America Wound Care Biologics Market Attractiveness Analysis by Product, 2022-2032
Figure 46: Latin America Wound Care Biologics Market Share and BPS Analysis by End User, 2022 & 2032
Figure 47: Latin America Wound Care Biologics Market Y-o-Y Growth Projections by End User, 2022-2032
Figure 48: Latin America Wound Care Biologics Market Attractiveness Analysis by End User, 2022-2032
Figure 49: Europe Wound Care Biologics Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 50: Europe Wound Care Biologics Market Value (US$ Mn) Forecast and Analysis, 2022-2032
Figure 51: Europe Wound Care Biologics Market Value Y-o-Y Growth and Forecast, 2017-2032
Figure 52: Europe Wound Care Biologics Market Incremental $ Opportunity, 2022-2032
Figure 53: Europe Wound Care Biologics Market Share Analysis by Country, 2022 & 2032
Figure 54: Europe Wound Care Biologics Market Y-o-Y Growth Projection by Country, 2022-2032
Figure 55: Europe Wound Care Biologics Market Attractiveness Analysis by Country, 2022-2032
Figure 56: Europe Wound Care Biologics Market Share and BPS Analysis by Wound Type, 2022 & 2032
Figure 57: Europe Wound Care Biologics Market Y-o-Y Growth Projections by Wound Type, 2022-2032
Figure 58: Europe Wound Care Biologics Market Attractiveness Analysis by Wound Type, 2022-2032
Figure 59: Europe Wound Care Biologics Market Share and BPS Analysis by Product, 2022 & 2032
Figure 60: Europe Wound Care Biologics Market Y-o-Y Growth Projections by Product, 2022-2032
Figure 61: Europe Wound Care Biologics Market Attractiveness Analysis by Product, 2022-2032
Figure 62: Europe Wound Care Biologics Market Share and BPS Analysis by End User, 2022 & 2032
Figure 63: Europe Wound Care Biologics Market Y-o-Y Growth Projections by End User, 2022-2032
Figure 64: Europe Wound Care Biologics Market Attractiveness Analysis by End User, 2022-2032
Figure 65: East Asia Wound Care Biologics Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 66: East Asia Wound Care Biologics Market Value (US$ Mn) Forecast and Analysis, 2022-2032
Figure 67: East Asia Wound Care Biologics Market Value Y-o-Y Growth and Forecast, 2017-2032
Figure 68: East Asia Wound Care Biologics Market Incremental $ Opportunity, 2022-2032
Figure 69: East Asia Wound Care Biologics Market Share Analysis by Country, 2022 & 2032
Figure 70: East Asia Wound Care Biologics Market Y-o-Y Growth Projection by Country, 2022-2032
Figure 71: East Asia Wound Care Biologics Market Attractiveness Analysis by Country, 2022-2032
Figure 72: East Asia Wound Care Biologics Market Share and BPS Analysis by Wound Type, 2022 & 2032
Figure 73: East Asia Wound Care Biologics Market Y-o-Y Growth Projections by Wound Type, 2022-2032
Figure 74: East Asia Wound Care Biologics Market Attractiveness Analysis by Wound Type, 2022-2032
Figure 75: East Asia Wound Care Biologics Market Share and BPS Analysis by Product, 2022 & 2032
Figure 76: East Asia Wound Care Biologics Market Y-o-Y Growth Projections by Product, 2022-2032
Figure 77: East Asia Wound Care Biologics Market Attractiveness Analysis by Product, 2022-2032
Figure 78: East Asia Wound Care Biologics Market Share and BPS Analysis by End User, 2022 & 2032
Figure 79: East Asia Wound Care Biologics Market Y-o-Y Growth Projections by End User, 2022-2032
Figure 80: East Asia Wound Care Biologics Market Attractiveness Analysis by End User, 2022-2032
Figure 81: South Asia & Oceania Wound Care Biologics Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 82: South Asia & Oceania Wound Care Biologics Market Value (US$ Mn) Forecast and Analysis, 2022-2032
Figure 83: South Asia & Oceania Wound Care Biologics Market Value Y-o-Y Growth and Forecast, 2017-2032
Figure 84: South Asia & Oceania Wound Care Biologics Market Incremental $ Opportunity, 2022-2032
Figure 85: South Asia & Oceania Wound Care Biologics Market Share Analysis by Country, 2022 & 2032
Figure 86: South Asia & Oceania Wound Care Biologics Market Y-o-Y Growth Projection by Country, 2022-2032
Figure 87: South Asia & Oceania Wound Care Biologics Market Attractiveness Analysis by Country, 2022-2032
Figure 88: South Asia & Oceania Wound Care Biologics Market Share and BPS Analysis by Wound Type, 2022 & 2032
Figure 89: South Asia & Oceania Wound Care Biologics Market Y-o-Y Growth Projections by Wound Type, 2022-2032
Figure 90: South Asia & Oceania Wound Care Biologics Market Attractiveness Analysis by Wound Type, 2022-2032
Figure 91: South Asia & Oceania Wound Care Biologics Market Share and BPS Analysis by Product, 2022 & 2032
Figure 92: South Asia & Oceania Wound Care Biologics Market Y-o-Y Growth Projections by Product, 2022-2032
Figure 93: South Asia & Oceania Wound Care Biologics Market Attractiveness Analysis by Product, 2022-2032
Figure 94: South Asia & Oceania Wound Care Biologics Market Share and BPS Analysis by End User, 2022 & 2032
Figure 95: South Asia & Oceania Wound Care Biologics Market Y-o-Y Growth Projections by End User, 2022-2032
Figure 96: South Asia & Oceania Wound Care Biologics Market Attractiveness Analysis by End User, 2022-2032
Figure 97: MEA Wound Care Biologics Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 98: MEA Wound Care Biologics Market Value (US$ Mn) Forecast and Analysis, 2022-2032
Figure 99: MEA Wound Care Biologics Market Value Y-o-Y Growth and Forecast, 2017-2032
Figure 100: MEA Wound Care Biologics Market Incremental $ Opportunity, 2022-2032
Figure 101: MEA Wound Care Biologics Market Share Analysis by Country, 2022 & 2032
Figure 102: MEA Wound Care Biologics Market Y-o-Y Growth Projection by Country, 2022-2032
Figure 103: MEA Wound Care Biologics Market Attractiveness Analysis by Country, 2022-2032
Figure 104: MEA Wound Care Biologics Market Share and BPS Analysis by Wound Type, 2022 & 2032
Figure 105: MEA Wound Care Biologics Market Y-o-Y Growth Projections by Wound Type, 2022-2032
Figure 106: MEA Wound Care Biologics Market Attractiveness Analysis by Wound Type, 2022-2032
Figure 107: MEA Wound Care Biologics Market Share and BPS Analysis by Product, 2022 & 2032
Figure 108: MEA Wound Care Biologics Market Y-o-Y Growth Projections by Product, 2022-2032
Figure 109: MEA Wound Care Biologics Market Attractiveness Analysis by Product, 2022-2032
Figure 110: MEA Wound Care Biologics Market Share and BPS Analysis by End User, 2022 & 2032
Figure 111: MEA Wound Care Biologics Market Y-o-Y Growth Projections by End User, 2022-2032
Figure 112: MEA Wound Care Biologics Market Attractiveness Analysis by End User, 2022-2032
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
At what pace is the wound care biologics market expected to increase over the next 10 years?
Global wound care biologics product demand is estimated to rise at 11% CAGR from 2022 to 2032.
At present what valuation does the wound care biologics market enjoy?
The global market for wound care biologics is currently valued at US$ 2.09 billion.
Which product type is most widely used across the world?
Global demand for biologic skin substitutes is predicted to surge at a CAGR of 11.5% through 2032.
What is the wound care biologics market predicted to be valued by 2032?
By 2032, the global wound care biologics market is anticipated to reach US$ 5.93 billion.
Which prime wound care biologics market players are profiled in this analysis?
Acell, Anika Therapeutics, Integra Lifesciences, Kerecis, Marine Polymer Technologies, Mimedx Group, Mölnlycke Health Care AB (Investor AB), Organogenesis, Osiris Therapeutics, and Smith & Nephew are key manufacturers of wound care biological products.
Wound Care Biologics Market